Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-22

FDA Approved: PREMPRO — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Prempro (conjugated estrogens and medroxyprogesterone acetate) submitted by Wyeth/Pfizer to modify the product l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREMPRO (Conjugated estrogens and medroxyprogesterone acetate)

Snippet

SUPPL AP for PREMPRO (CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE)